Safety Data Of Vaccines
- All
- News
- Videos
-
Akhilesh Yadav Demands Government To Disclose Safety Data Of Covid Jabs
Samajwadi Party president Akhilesh Yadav on Wednesday demanded the government to publicly share data on the safety and efficacy of various anti-Covid vaccines.
-
Chinese Vaccines Show Safety But Lack Data: WHO Experts
WHO vaccine experts said Wednesday that an interim analysis of clinical trial data from two Chinese Covid-19 vaccines showed they demonstrated "safety and good efficacy", but that more data was needed.
-
Data Suggests No Increase In Blood Clots After AstraZeneca Vaccine: WHO
The World Health Organization's vaccine safety experts gave renewed backing to AstraZeneca's Covid-19 jab on Friday, having reviewed reports of blood clotting after immunisation.
-
No Evidence Of Increased Blood Clot Risk From Vaccine, Says AstraZeneca
AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots.
-
Covaxin 81% Effective, Works Against UK Variant, Claims Bharat Biotech
Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial results for a vaccine cleared in January amid concerns over safety and efficacy.
-
Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V
Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21
-
Aadhaar Not Mandatory for Registration on Co-Win Portal, Says Government
Aadhaar card is not mandatory to register on the government’s COVID-19 vaccination portal, Co-Win, Union Minister of State for Health Ashwini Choubey said in Lok Sabha on Friday.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Great Milestone: Bharat Biotech On Approval For Emergency Use Of Covaxin
Expressing delight over the approval on restricted emergency use of its COVID-19 vaccine Covaxin, Bharat Biotech on Sunday said it has generated excellent safety data with robust immune responses to multiple viral proteins that persist and their goal is to provide global access to populations that need it the most.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
No Known Data On Quality, Efficacy And Safety Of Russian Vaccine: Germany
Germany on Tuesday raised doubts over the quality and safety of Russia's coronavirus vaccine, stressing that drug approval is granted in the European Union only after full clinical trials.
-
Trouble Mounts For Dengue Vaccine Over Safety Concerns
The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases.
-
Akhilesh Yadav Demands Government To Disclose Safety Data Of Covid Jabs
Samajwadi Party president Akhilesh Yadav on Wednesday demanded the government to publicly share data on the safety and efficacy of various anti-Covid vaccines.
-
Chinese Vaccines Show Safety But Lack Data: WHO Experts
WHO vaccine experts said Wednesday that an interim analysis of clinical trial data from two Chinese Covid-19 vaccines showed they demonstrated "safety and good efficacy", but that more data was needed.
-
Data Suggests No Increase In Blood Clots After AstraZeneca Vaccine: WHO
The World Health Organization's vaccine safety experts gave renewed backing to AstraZeneca's Covid-19 jab on Friday, having reviewed reports of blood clotting after immunisation.
-
No Evidence Of Increased Blood Clot Risk From Vaccine, Says AstraZeneca
AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots.
-
Covaxin 81% Effective, Works Against UK Variant, Claims Bharat Biotech
Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial results for a vaccine cleared in January amid concerns over safety and efficacy.
-
Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V
Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21
-
Aadhaar Not Mandatory for Registration on Co-Win Portal, Says Government
Aadhaar card is not mandatory to register on the government’s COVID-19 vaccination portal, Co-Win, Union Minister of State for Health Ashwini Choubey said in Lok Sabha on Friday.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Great Milestone: Bharat Biotech On Approval For Emergency Use Of Covaxin
Expressing delight over the approval on restricted emergency use of its COVID-19 vaccine Covaxin, Bharat Biotech on Sunday said it has generated excellent safety data with robust immune responses to multiple viral proteins that persist and their goal is to provide global access to populations that need it the most.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
No Known Data On Quality, Efficacy And Safety Of Russian Vaccine: Germany
Germany on Tuesday raised doubts over the quality and safety of Russia's coronavirus vaccine, stressing that drug approval is granted in the European Union only after full clinical trials.
-
Trouble Mounts For Dengue Vaccine Over Safety Concerns
The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases.
